Novan (NOVN) Focuses Strategic Direction and Announces Restructuring
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Nasdaq futures fall as oil prices jump, key earnings loom
- Brent hits five-month high as attacks on ships, Saudi sites fuel supply worries
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
Novan Focuses Strategic Direction and Announces Restructuring
May 31, 2023 4:05 PM EDT Company directing resources on the potential approval of berdazimer gel, 10.3% (SB206) for molluscum contagiosum
Process to explore a sale or out-license of commercial assets or other business transaction continues
Continued progress toward PDUFA goal date of January 5, 2024, for berdazimer gel, 10.3%
DURHAM, N.C., May 31, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (the Company or Novan) (Nasdaq: NOVN), today announced that following an evaluation of its commercial and developmental stage assets, it has decided to sharpen its focus and resources on berdazimer gel, 10.3%... More



